Between May and November 2020, the agency asked at least six companies to voluntarily recall several lots of extended-release metformin after agency lab testing detected unacceptable levels of NDMA.
It comes as the FDA has made a second recall for Nitroglycerin Lingual Spray, which is administered to patients to relieve pain caused by coronary artery disease.
What is Metformin?
According to the NHS: “Metformin is a medicine used to treat type 2 diabetes, and to help prevent type 2 diabetes if you’re at risk of developing it.